Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen by Alessandra Torina et al.
Torina et al. Parasites & Vectors 2014, 7:10
http://www.parasitesandvectors.com/content/7/1/10RESEARCH Open AccessControl of tick infestations and pathogen
prevalence in cattle and sheep farms vaccinated
with the recombinant Subolesin-Major Surface
Protein 1a chimeric antigen
Alessandra Torina1,2, Juan A Moreno-Cid3, Valeria Blanda1, Isabel G Fernández de Mera3, José M Pérez de la Lastra3,
Salvatore Scimeca1, Marcellocalogero Blanda1, Maria Elena Scariano1, Salvatore Briganò1, Rosaria Disclafani1,
Antonio Piazza1, Joaquín Vicente3, Christian Gortázar3, Santo Caracappa1, Rossella Colomba Lelli1
and José de la Fuente3,4*Abstract
Background: Despite the use of chemical acaricides, tick infestations continue to affect animal health and production
worldwide. Tick vaccines have been proposed as a cost-effective and environmentally friendly alternative for tick
control. Vaccination with the candidate tick protective antigen, Subolesin (SUB), has been shown experimentally to be
effective in controlling vector infestations and pathogen infection. Furthermore, Escherichia coli membranes containing
the chimeric antigen composed of SUB fused to Anaplasma marginale Major Surface Protein 1a (MSP1a) (SUB-MSP1a)
were produced using a simple low-cost process and proved to be effective for the control of cattle tick, Rhipicephalus
(Boophilus) microplus and R. annulatus infestations in pen trials. In this research, field trials were conducted to
characterize the effect of vaccination with SUB-MSP1a on tick infestations and the prevalence of tick-borne pathogens
in a randomized controlled prospective study.
Methods: Two cattle and two sheep farms with similar geographical locations and production characteristics were
randomly assigned to control and vaccinated groups. Ticks were collected, counted, weighed and classified and the
prevalence of tick-borne pathogens at the DNA and serological levels were followed for one year prior to and 9 months
after vaccination.
Results: Both cattle and sheep developed antibodies against SUB in response to vaccination. The main effect of the
vaccine in cattle was the 8-fold reduction in the percent of infested animals while vaccination in sheep reduced tick
infestations by 63%. Female tick weight was 32-55% lower in ticks collected from both vaccinated cattle and sheep
when compared to controls. The seroprevalence of Babesia bigemina was lower by 30% in vaccinated cattle, suggesting
a possible role for the vaccine in decreasing the prevalence of this tick-borne pathogen. The effect of the vaccine in
reducing the frequency of one A. marginale msp4 genotype probably reflected the reduction in the prevalence of a
tick-transmitted strain as a result of the reduction in the percent of tick-infested cattle.
Conclusions: These data provide evidence of the dual effect of a SUB-based vaccine for controlling tick infestations
and pathogen infection/transmission and provide additional support for the use of the SUB-MSP1a vaccine for tick
control in cattle and sheep.
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Tick infestations affect animal health and production
worldwide, both for the impact on animal weight gain
and milk production and for the pathogens transmitted
by these ectoparasites [1-4]. Acaricides are a major com-
ponent of integrated tick control strategies, but their ap-
plication has had limited efficacy in reducing tick
infestations and is often accompanied by serious draw-
backs, including the selection of acaricide-resistant ticks,
environmental contamination and contamination of milk
and meat products with drug residues [4]. All of these
issues reinforce the need for alternative approaches to
control tick infestations and pathogen transmission, in-
cluding the use of vaccines with tick antigens [5-7].
In the early 1990s, commercial vaccines containing the
recombinant Rhipicephalus (Boophilus) microplus BM86
gut antigen were developed and commercialized for the
control of cattle tick infestations [8]. These vaccines
proved to be a cost-effective alternative for cattle tick con-
trol through the reduction of the number of engorged fe-
male ticks, their weight and reproductive capacity and the
prevalence of some tick-borne pathogens [1,8]. However,
BM86-based vaccines have limited efficacy against other
tick species and thus new vaccines are needed for the con-
trol of multiple tick species infestations, which occur in
many areas used for animal husbandry [5,6,8].
Recently, Subolesin (SUB) was discovered as a new
candidate tick protective antigen [9,10]. Vaccination trials
with recombinant SUB and its ortholog in insects, Akirin,
demonstrated effective control of arthropod vector infesta-
tions in various hard and soft tick species, mosquitoes, sand
flies, poultry red mites and sea lice by reducing their
numbers, weight, oviposition, fertility and/or molting
and also reduced tick infection with tick-borne pathogens,
Anaplasma phagocytophilum, Anaplasma marginale,
Babesia bigemina and Borrelia burgdorferi [11]. Further-
more, the chimeric antigen, tick SUB fused with A. marginale
Major Surface Protein 1a (MSP1a; SUB-MSP1a), was
produced in Escherichia coli using a simple and low-cost
process. Use of a vaccine with bacterial membranes containing
the SUB-MSP1a chimera with surface-exposed SUB provided
control of R. microplus and R. annulatus tick infestations
[12,13], and this vaccine formulation was proposed as a
low-cost and effective alternative means of tick control.
However, vaccination trials with SUB-MSP1a were con-
ducted under controlled conditions and only in cattle ex-
perimentally infested with R. microplus and R. annulatus
[12], which limit the assessment of the potential impact of
this vaccine for the control of tick infestations and the
prevalence of tick-borne pathogens under field conditions.
To address these limitations, herein we conducted field
trials on cattle and sheep farms in order to assess the effi-
cacy of the SUB-MSP1a vaccine for the control of multiple
tick species and tick-borne pathogens.Methods
Experimental design and rationale
The field trial was designed to characterize the effect of
vaccination with SUB-MSP1a on tick infestations and
the prevalence of tick-borne pathogens at the DNA and
serological levels in a randomized controlled prospective
study. Two cattle and two sheep farms with similar
geographical locations and production characteristics
were randomly assigned as control or vaccinated herds.
These farms were followed for one year prior to vaccin-
ation and 9 months after vaccination. Vaccine trials were
approved by the Italian Ministry of Health (Direzione
Generale della Sanita’ Aimale e dei Farmaci Veterinari,
permit no. DGSAF 0002336-P-08/02/2011).
Study site
Two cattle farms (identified as G for vaccinated and M
for control) and two sheep farms (identified as C for
vaccinated and L for control) located in the Province of
Palermo, Sicily, were included in the trial (Figure 1).
Cattle farms had a similar location (G, 38.00738 and
13.25156; M, 38.03039 and 13.23532), altitude (G, 950
m; M, 700 m), and number of animals (G, N = 35; M,
N = 31). Sheep farms also had a similar location (C,
38.02188 and 12.98748; L, 38.03482 and 13.08531), alti-
tude (C, 150 m; L, 175 m), and number of animals (C,
N = 133; L, N = 123). Land use was also similar between
cattle and sheep farms (Figure 1).
Vaccine preparation and vaccination
Unless otherwise indicated, all reagents used in this work
were purchased either from Sigma-Aldrich (St Louis, MO,
USA) or VWR International Eurolab S.L. (Mollet del
Vallés, Barcelona, Spain). The vaccine containing bacterial
membranes with surface-exposed R. microplus SUB-
MSP1a chimeric antigens was prepared as previously
described [12]. Briefly, recombinant E. coli JM109 cells
transformed with the pMBXAF3 expression vector were
propagated in 1 litre flasks containing 250 ml Luria–
Bertani (LB) broth supplemented with 10 g/l tryptone,
5 g/l yeast extract, 10 g/l NaCl, 50 μg/ml ampicillin and
0.4% glucose (Laboratorios CONDA S.A., Madrid, Spain)
for 2 h at 37ºC and 200 rpm and then for 5.5 h after
addition of 0.5 mM final concentration of isopropyl-β-d-
thiogalactopyranoside (IPTG) for induction of recombinant
protein production [14]. The cells were harvested by
centrifugation at 10,000 x g for 15 min at 4ºC and then 1 g
of cell pellet was resuspended in 5 ml of disruption buffer
(100 mM Tris HCl, pH 7.5, 150 mM NaCl, 1 mM PMSF,
5 mM MgCl2 · 6H2O and 0.1% (v/v) Triton X-100) and
disrupted using a cell sonicator (Model MS73; Bandelin
Sonopuls, Berlin, Germany). After disruption, the in-
soluble protein fraction containing the membrane-
bound SUB-MSP1a was collected by centrifugation at
Figure 1 Localization of cattle and sheep farms and land use in the study area. Maps were constructed using the Esri ArcMap 9.3 software.
(A) Localization of the study area in the Province of Palermo, Sicily. The digital elevation model was processed through the interpolation of level curves
values of the Sicilian region, obtaining the elevations of study sites. (B) The land use of the areas near to the farms was obtained from Corine Land
Cover 2006 processed by the European Environmental Agency describing the coverage and, in part, the use of the soil in Europe. Spatial selection
allowed deriving the different levels of the land use classes that affect the areas where the farms are placed. (C) The analysis showed that vaccinated
and control sheep (L and C) and cattle (M and G) farms are located close to each other in the same region and have similar land use.
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insoluble protein fraction containing over 50% of total
proteins corresponding to the SUB-MSP1a chimera was
resuspended in PBS, pH 7.4 and adjuvated in Montanide
ISA 50 V2 (Seppic, Paris, France) at a concentration of
125 μg/ml.All cattle and sheep present in the farms, including
newborns at month 4 of age and adults imported during
the trial were treated. Animals in cattle farm G and
sheep farm C were vaccinated with two immunization
doses of 1 ml containing 100 μg of the antigen prepa-
ration. Animals in cattle farm M and sheep farm L were
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as control. Injections were done intramuscularly in the
back of the animals using a 2.5-ml syringe and an 18G
needle. Cattle in vaccinated and control farms were
vaccinated or injected with adjuvant/saline on March
19th and April 20th, 2012. Sheep in vaccinated and
control farms were vaccinated or injected with adjuvant/
saline on March 13th and April 12th, 2012. Cattle in both
vaccinated and control farms were treated with tilmicocin
to prevent pneumonia prior to the first vaccination or ad-
juvant/saline injection following the manufacturer’s recom-
mendations (TILMI-kel; KELA Laboratoria, Hoogstraten,
Belgium). No contraindications have been described for
this or similar products with respect to response to
vaccination.
Sample collection
In each farm, ticks and EDTA-treated and untreated
blood samples were collected from all animals before
each immunization and four weeks after the last
immunization and then monthly from randomly selected
individuals representing 10% of the animals present in
the farm. Serum was separated from blood samples by
centrifugation and stored with EDTA-treated blood sam-
ples at −20°C.
Characterization of tick infestations
Collected ticks were counted for each animal, identified
by morphological features using standard taxonomic
keys for Italian Ixodidae [15] and preserved in 70% etha-
nol. Replete female ticks were weighed individually and
the weights (mg) were compared between animals in the
vaccinated farm before and after vaccination and be-
tween vaccinated and control farms by Student’s t-test
with unequal variance (p = 0.05). Tick infestations (ticks/
animal) were modeled separately for cattle and sheep
using a generalized lineal model with binomial function
and logit error with the dependent variables presence/
absence of ticks and sampling time and farm as explana-
tory variables (p = 0.01; SPSS Statistics version 19,
Surrey, UK). Tick infestations (ticks/animal) were com-
pared between vaccinated and control animals using an
ANOVA test (p = 0.05). The percent of animals infested
with ticks before and after vaccination was compared
between vaccinated and control farms by Student’s t-test
with unequal variance (p = 0.05).
Pathogen DNA identification by PCR
DNA was extracted from EDTA-treated blood samples
using the PureLink Genomic Mini kit (Invitrogen, Carlsbad,
CA, USA) following the manufacturer’s instructions. DNA
samples were analyzed by PCR as reported previously to
detect the presence of DNA from Anaplasma spp. [16] in
all samples and positive samples were then analyzed forA. marginale/A. ovis [17,18] and A. phagocytophilum [19]
DNA. The presence of DNA from A. marginale [17,18],
Babesia bovis [20], B. bigemina [20] and Theileria annu-
lata [21] was analyzed in cattle only while DNA from
A. ovis, B. ovis [22] and T. ovis [23] was characterized in
sheep only. Coxiella burnetii [24] and A. phagocytophilum
[19] DNA was characterized in both cattle and sheep
samples.
PCRs were performed in a reaction buffer containing
1.5 mM MgCl2, 0.2 mM dNTPs, forward and reverse
primers at a concentration of 0.4 mM, and 0.025 U/μl of
Taq polymerase (5 U/μl) (Promega, Madison, WI, USA).
For each reaction, a positive control consisting of patho-
gen DNA and a negative control in which DNA was
replaced by water were used. PCR products were
visualized after agarose gel electrophoresis containing
10 μg/ml ethidium bromide. Pathogen DNA prevalence
(% positive animals) was compared between animals in
the vaccinated farm before and after vaccination and
between vaccinated and control farms by Student’s t-test
with unequal variance (p = 0.05).
Serological analyses
Serum antibody titers were determined using antigen-
specific indirect ELISAs against SUB-MSP1a or SUB
[12,25]. Briefly, purified antigens (0.1 μg/well) were used
to coat ELISA plates overnight at 4°C. Plates were then
washed three times with PBS/0.1% tween 20, pH 7.2. Sera
were serially diluted to 1:100 and 1:1000 in PBS/0.5%
Tween 20, pH 7.2 (PBST) and 10% fetal bovine serum
(Sigma). The plates were incubated with the diluted sera
for 1 hr at 37°C, washed three times with PBST and then
incubated with 1:10,000 rabbit anti-bovine immunoglubo-
lin G (IgG)-horseradish peroxidase conjugate (Sigma) for
1 hr at 37°C. Plates were washed three times with PBST
and the color reaction was developed after incubation at
37°C with 200 μl of the substrate SIGMAFAS™OPD
(Sigma). The reaction was stopped after 20 min with a so-
lution of 4N sulphuric acid and the O.D.450nm was deter-
mined. Antibody titers were considered positive when
they yielded an O.D.450nm value at least twice as high as
the preimmune serum. Antibody titers were expressed as
the O.D.450nm value for the highest serum dilution
(1:1000) and compared between vaccinated and placebo
control cattle using an ANOVA test (p = 0.05).
Bovine and ovine serum samples were analyzed using
commercial ELISA kits for the presence of antibodies
against A. marginale/A. ovis (VMRD, Pullman, WA,
USA), B. bigemina (Svanova Biotech AB, Uppsala,
Sweden) and C. burnetii (ID.vet, Montpellier, France)
following manufacturer’s recommendations. The pres-
ence of antibodies against T. annulata was evaluated by
immunofluorescence using antigen slides prepared as
described previously [26]. Pathogen seroprevalence
Figure 2 Antibody response in cattle and sheep. Serum antibody titers to the recombinant vaccine antigen, SUB-MSP1a, were determined by
ELISA in (A) cattle and (B) sheep. Antibody titers were expressed as the OD450nm value for the 1:1000 serum dilution, represented as Ave ± SD
and compared between vaccinated and control animals using an ANOVA test (*p < 0.05). The time of immunization shots are indicated
with arrows.
Figure 3 Tick infestations in cattle and sheep. Ticks found on animals in both vaccinated and control (A) cattle and (B) sheep farms were
counted and stored in 70% ethanol. Tick infestations (ticks/animal) were represented as Ave ± SD and compared between vaccinated and control
animals using an ANOVA test (*p < 0.05). The time of immunization shots are indicated with arrows.
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the vaccinated farm before and after vaccination and
between vaccinated and control farms by Student’s t-test
with unequal variance (p = 0.05).
PCR amplification and sequencing of A. marginale and A.
ovis major surface protein 4 (msp4) gene
Total DNA was extracted from EDTA-treated blood sam-
ples and analyzed by msp4 PCR as described before [17] in
all samples positive for Anaplasma spp. DNA. The msp4Figure 4 Tick species infesting cattle and sheep. Ticks collected from (A
control farms were classified, grouped according to tick genera and represamplicons were purified using the MinElute PCR Puri-
fication Kit (Qiagen, Hilden, Germany) and sequenced
(Secugen S.L., Madrid, Spain). Genotype frequencies were
calculated as the percent of animals positive for each
genotype. A correlation analysis was conducted to analyze
genotype frequencies in time using Excel. The msp4 se-
quences were aligned using the program AlignX (Vector
NTI Suite V 5.5, InforMax, North Bethesda, MD, USA).
Themsp4 sequences were submitted to the GenBank under
accession numbers [GenBank: KF739427-KF739433]., B) cattle and (C, D) sheep in both (A, C) vaccinated and (B, D)
ented as percent of total ticks collected throughout the experiment.
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Antibody response in cattle and sheep vaccinated
with the SUB-MSP1a antigen
Cattle and sheep from vaccinated herds developed anti-
bodies against SUB-MSP1a after vaccination, reaching a
peak one month after the last immunization (Figure 2A
and B). Significantly higher antibody titers against the
vaccine antigen, SUB-MSP1a (Figure 2A and B) or re-
combinant SUB [Additional file 1: Figures S1 and S2]
persisted in vaccinated animals for three months after
the last immunization when compared to control
animals. These results were similar to those previously
obtained in cattle vaccinated with SUB-MSP1a [12].
Antibody titers to MSP1a were not determined because
they are irrelevant for the studies reported here in part
because antibodies in livestock persistently infected with
Anaplasma react with MSP1a, which would precludeFigure 5 Infestation with more abundant tick species in cattle and sh
sheep were counted, represented as ticks per animal (Ave ± SD) and comp
(*p < 0.05). The time of immunization shots are indicated with arrows.assessment of the humoral response to this part of the
antigen after vaccination.
Effect of vaccination on tick infestations on cattle and sheep
One of the effects of SUB-MSP1a and other tick vac-
cines is the reduction in tick infestations [5,8,10,12]. The
tick infestation rate (ticks/animal) was very low in the
year before vaccination with no differences between cat-
tle farms (Figure 3A; generalized lineal model, p = 0.3)
but did differ between sheep farms with higher tick
infestations in farm C (Figure 3B; generalized lineal
model, p < 0.0001). However, tick infestations were
higher in the second year of the experiment (Figure 3A
and B), probably reflecting year-to-year variations in tick
populations that occur under natural conditions in Sicily
[27]. Differences were not observed in tick infestation rates
between vaccinated and control cattle for both total tickeep. The most abundant tick species found on (A-C) cattle and (D-F)
ared between vaccinated and control animals using an ANOVA test
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female tick counts [Additional file 1: Figure S3]. However,
total tick counts (Figure 3B; generalized lineal model,
p = 0.003) and female tick counts [Additional file 1: Figure
S4] per animal were lower by 63% and 60%, respectively in
vaccinated sheep when compared to control animals one
month after the last immunization. These results suggested
differences between cattle and sheep that could be
explained by different factors such as higher tick infesta-
tions in cattle when compared to sheep (Figure 3A and B)
that require more time for the vaccine to reduce tick infes-
tations, differences in tick species infesting cattle and sheep
and/or other factors.
Ticks collected on vaccinated and control animals
throughout the experiment were classified and included
Hyalomma lusitanicum, Haemaphisalis punctata, Rhipice-
phalus bursa, Rhipicephalus sanguineus, RhipicephalusFigure 6 Tick weight and percent infested cattle. (A) Replete female tic
weight (mg) represented as Ave ± SD and compared between cattle in the
and control cattle by Student’s t-test with unequal variance (*p < 0.05). (B)
immunization shots are indicated with arrows. (C) Percent infested cattle b
SD and compared between vaccinated and control cattle by Student’s t-te
infested cattle in vaccinated and control farms before and after vaccination
vaccinated and control animals.turanicus, Rhipicephalus annulatus and Ixodes ricinus in
cattle, and Dermacentor marginatus, R. sanguineus,
R. turanicus and Haemaphisalis sulcata in sheep. To
address the differences between ticks infesting cattle and
sheep, ticks were grouped according to their genera
(Figure 4A-D). Hyalomma spp., followed by Rhipicephalus
spp. and Haemaphysalis spp. were the predominant tick
species found on cattle (Figure 4A and B). However, the
predominant tick species infesting sheep were Rhipicepha-
lus spp. followed by Haemaphysalis spp. and Dermacentor
spp. (Figure 4C and D). These tick species are among the
most abundant species found in the study area and the re-
sults reflect differences between preferred hosts for these
species [27,28].
The tick infestation rate was then characterized for the
most abundant tick species infesting cattle (Figure 5A-C)
and sheep (Figure 5D-F). The appearance of theks collected from vaccinated and control cattle were weighed, the
vaccinated farm before and after vaccination and between vaccinated
Percent infested cattle in vaccinated and control farms. The time of
efore and after vaccination with SUB-MSP1a was represented as Ave ±
st with unequal variance (*p < 0.05). (D) Range values for the percent
. Average values are shown to illustrate differences between
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ations in developmental seasonality for ticks [27]. In cattle,
only Haemaphysalis spp. infestations were lower in vacci-
nated animals after vaccination (Figure 5C) while in sheep
only Dermacentor spp. infestations were lower in vaccina-
ted animals after vaccination (Figure 5D). Interestingly,
Rhipicephalus spp. infestations were higher or similar in
vaccinated cattle and sheep, respectively when compared
to control animals (Figure 5B and E). At first, these results
suggested a contradiction with previous experiments in
which the SUB-MSP1a vaccine was protective against R.
microplus and R. annulatus infestations in cattle [12].
However, the most abundant Rhipicephalus spp. collected
from infested animals in this trial corresponded to R.
bursa, R. sanguineus and R. turanicus in cattle and R. san-
guineus and R. turanicus in sheep. These results suggested
that the efficacy of the SUB-MSP1a vaccine differsFigure 7 Tick weight and percent infested sheep. (A) Replete female ti
weight (mg) represented as Ave ± SD and compared between sheep in the
vaccinated and control sheep by Student’s t-test with unequal variance (*p
The time of immunization shots are indicated with arrows. (C) Percent infe
represented as Ave ± SD and compared between vaccinated and control s
values for the percent infested sheep in vaccinated and control farms befo
differences between vaccinated and control animals.between cattle and sheep and between different tick spe-
cies (Figure 5A-F).
Previous results with the SUB-MSP1a vaccine showed that
vaccination not only reduced cattle tick infestations but also
the weight of replete female ticks [12]. Additionally, field ap-
plication of BM86-based commercial vaccines showed a re-
duction in the percent of infested cattle [8]. Therefore, the
effect of the vaccine was characterized on the weight of fe-
male ticks collected from cattle and sheep and the percent
of infested animals in both control and vaccinated farms.
The results showed Hyalomma spp. and Haemaphysalis
spp. but not Rhipicephalus spp. female ticks collected from
vaccinated cattle had significantly 32-39% lower weights
when compared to the same animals before vaccination and
to control cattle (Figure 6A). Furthermore, the percent of
infested cattle was higher before vaccination but lower after
vaccination in the vaccinated farm at some time pointscks collected from vaccinated and control sheep were weighed, the
vaccinated farm before and after vaccination and between
< 0.05). (B) Percent infested sheep in vaccinated and control farms.
sted sheep before and after vaccination with SUB-MSP1a was
heep by Student’s t-test with unequal variance (*p < 0.05). (D) Range
re and after vaccination. Average values are shown to illustrate
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of the number of infested cattle before and after vaccination
showed that while the percent of infested animals was
significantly higher in cattle in the vaccinated farm when
compared to control cattle before vaccination, differences
were not observed after vaccination between vaccinated
and control cattle but only in the control farm before and
after vaccination (Figure 6C). These results showed that
vaccination with SUB-MSP1a maintained a similar percent
of infested cattle after vaccination while in the control farm
the percent of infested animals increased in more than
8-fold in the second year of the trial (Figure 6D).
In sheep, 43-55% reduction in female tick weight was
recorded for Rhipicephalus sp. and Haemaphysalis spp.
collected from vaccinated animals when compared to the
same animals before vaccination and to control sheep
(Figure 7A). However, the percent of infested sheep was not
affected by vaccination with SUB-MSP1a (Figure 7B-D).Figure 8 Prevalence of tick-borne pathogens in cattle. (A) The seropre
determined by ELISA, represented as Ave ± SD and compared between cat
vaccinated and control cattle by Student’s t-test with unequal variance (*p
(B) The DNA prevalence (%) for A. marginale in vaccinated and control catt
between cattle in the vaccinated farm before and after vaccination and be
variance (*p < 0.05). The time of immunization shots are indicated with arro
control cattle was determined by PCR, represented as Ave ± SD and compa
vaccination and between vaccinated and control cattle by Student’s t-test
indicated with arrows.Taken together, these results showed that the main
effect of the SUB-MSP1a vaccine in cattle was the reduc-
tion in the percent of infested animals but not in the tick
infestation rate of these animals. On the contrary,
vaccination in sheep did not affect the percent of infested
animals but reduced tick infestations. The reduction of
female tick weight was observed in ticks collected from
both vaccinated cattle and sheep.
Effect of vaccination on the prevalence of tick-borne
pathogens
The ultimate goal of tick vaccines is to reduce the preva-
lence of tick-borne diseases [7]. Tick vaccines have been
shown to reduce the prevalence of tick-borne pathogens
by reducing tick infestations and thus the exposure of sus-
ceptible hosts to pathogen transmission (e.g. BM86-based
vaccine; [8]) and through reduction of tick vector capacity
(e.g. SUB; [10,11]). Importantly, vaccination with SUB hasvalence (%) of B. bigemina in vaccinated and control cattle was
tle in the vaccinated farm before and after vaccination and between
< 0.05). The time of immunization shots are indicated with arrows.
le was determined by PCR, represented as Ave ± SD and compared
tween vaccinated and control cattle by Student’s t-test with unequal
ws. (C) The DNA prevalence (%) for T. annulata in vaccinated and
red between cattle in the vaccinated farm before and after
with unequal variance (*p < 0.05). The time of immunization shots are
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pathogen infection/transmission, thus having a dual effect
on reducing tick-borne diseases [11,29].
In our trial, the prevalence of tick-borne pathogens
that has been described infecting cattle and/or sheep in
Sicily [28,30-33] was analyzed at the DNA (A. marginale,
A. ovis, A. phagocytophilum, B. bovis, B. bigemina, B.
ovis, T. annulata, T. ovis and C. burnetii) and serology
(Anaplasma spp., B. bigemina,T. annulata and C. burnetii)
levels. The prevalence of A. marginale, B. bovis, B. bigemina
and T. annulata was analyzed in cattle only while the
prevalence of A. ovis, B. ovis and T. ovis was characterized
in sheep only. C. burnetii and A. phagocytophilum preva-
lence were characterized in both cattle and sheep.
The results showed less than 1% DNA prevalence in
both vaccinated and control cattle throughout the period
of the trial for A. phagocytophilum, B. bigemina, B. bovis
and C. burnetii (data not shown). However, B. bigeminaFigure 9 Prevalence of tick-borne pathogens in sheep. (A) The seropre
determined by ELISA, represented as Ave ± SD and compared between she
vaccinated and control sheep by Student’s t-test with unequal variance (*p
(B) The seroprevalence (%) of C. burnetii in vaccinated and control sheep w
between sheep in the vaccinated farm before and after vaccination and be
variance (*p < 0.05). The time of immunization shots are indicated with arro
sheep was determined by PCR, represented as Ave ± SD and compared be
between vaccinated and control sheep by Student’s t-test with unequal va
with arrows.seroprevalence decreased by 30% in vaccinated cattle
after vaccination when compared to controls (Figure 8A),
suggesting a role for the vaccine in reducing pathogen
transmission. As expected for animals that develop per-
sistent infection, the seroprevalence for Anaplasma spp.
was higher than 90% throughout the experiment and did
not change between vaccinated and control cattle nor
before and after vaccination [Additional file 1: Figure
S5]. For A. marginale DNA prevalence, the results
showed an increase after vaccination but with similar
levels for vaccinated and control cattle (Figure 8B). The
seroprevalence for C. burnetii was less than 1% in cattle
farm G throughout the experiment, while peaks of posi-
tive antibodies were observed in farm M but did not
differ between vaccinated and control cattle nor before
and after vaccination [Additional file 1: Figure S6]. The
prevalence of T. annulata DNA increased after
vaccination in control but not in vaccinated cattle butvalence (%) of Anaplasma spp. in vaccinated and control sheep was
ep in the vaccinated farm before and after vaccination and between
< 0.05). The time of immunization shots are indicated with arrows.
as determined by ELISA, represented as Ave ± SD and compared
tween vaccinated and control sheep by Student’s t-test with unequal
ws. (C) The DNA prevalence (%) for A. ovis in vaccinated and control
tween sheep in the vaccinated farm before and after vaccination and
riance (*p < 0.05). The time of immunization shots are indicated
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http://www.parasitesandvectors.com/content/7/1/10did not differ between vaccinated and control animals
(Figure 8C). Similarly, T. annulata seroprevalence was
high until the end of the experiment and did not differ
between vaccinated and control cattle throughout the
experiment [Additional file 1: Figure S7].
In sheep, less than 1% DNA prevalence was observed
for A. phagocytophilum, B. ovis and C. burnetii in both
vaccinated and control animals throughout the experi-
ment (data not shown). The seroprevalence for
Anaplasma spp. was higher in control than in vaccinated
sheep but both before and after vaccination (Figure 9A).
C. burnetii seroprevalence was also higher in control
than in vaccinated sheep but decreased by 37% in vacci-
nated sheep after vaccination (Figure 9B). In agreement
with serological results, A. ovis DNA prevalence was
higher in control than in vaccinated sheep but bothFigure 10 Characterization of the A. marginale msp4 genotypes in cat
sequenced and the frequency (%) for each genotype represented in (A) va
immunization shot. (C) The msp4 sequences of each genotype were aligne
number DQ000618). Sequence positions (the adenine in the translation init
were identified. Asterisks represent sequence positions identical to the refe
abundant A. marginale msp4 genotypes in vaccinated and control cattle. D
analysis was conducted to analyze genotype frequencies in time using Excbefore and after vaccination (Figure 9C). The prevalence
of T. ovis DNA was high throughout the experiment
with no differences between vaccinated and control
sheep [Additional file 1: Figure S8].
In summary, the results of vaccination with SUB-
MSP1a on the prevalence of tick-borne pathogens sug-
gested a role for the vaccine in decreasing B. bigemina
seroprevalence in cattle. This finding is in agreement
with the results of previous studies and demonstrated
that vaccination with SUB reduces B. bigemina DNA
levels in ticks fed on infected and vaccinated cattle
[25,29]. Additionally, this result may reflect the reduc-
tion in the percent of infested animals shown in cattle
vaccinated with SUB-MSP1a. However, in contrast to
previous results in cattle vaccinated with SUB [25,29],
vaccination with SUB-MSP1a did not reduce thetle. The A. marginale msp4 coding region was amplified by PCR,
ccinated and (B) control cattle. Dashed line represents time of last
d and compared to the reference sequence (GenBank accession
iation codon ATG corresponds to position 1) with polymorphisms
rence sequence. (D) Distribution in the frequencies of the most
ashed line represents time of last immunization shot. A correlation
el and represented only when the correlation coefficient (R2) was ≥0.5.
Torina et al. Parasites & Vectors 2014, 7:10 Page 13 of 15
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of the vaccine was on the decrease of C. burnetii sero-
prevalence in vaccinated but not in control animals after
vaccination. However, this result may reflect better farm
management and animal health conditions in sheep farm
C when compared to farm L, factors known to affect the
prevalence of C. burnetii [34,35] and other tick-borne
pathogens [36]. As shown in field trials using BM86-
based commercial vaccines [1], the reduction in tick in-
festations in sheep vaccinated with SUB-MSP1a would
require several years of vaccination before it could de-
crease the prevalence of some tick-borne pathogens.
Characterization of the A. marginale and A. ovis msp4
genotypes in cattle and sheep
A. marginale and A. ovis are transmitted not only bio-
logically by ticks, but also mechanically by biting insects
and blood contaminated fomites [37]. Therefore, despiteFigure 11 Characterization of the A. ovis msp4 genotypes in sheep. T
the frequency (%) for each genotype represented in (A) vaccinated and (B
A correlation analysis was conducted to analyze genotype frequencies in ti
(R2) was ≥0.5. (C) The msp4 sequences of each genotype were aligned and
EU436160). Sequence positions (the adenine in the translation initiation co
identified. Asterisks represent sequence positions identical to the referencethe fact that vaccination with SUB-MSP1a did not affect
Anaplasma spp. prevalence in this trial, we characterized
A. marginale and A. ovis msp4 genotypes trying to iden-
tify a possible effect of the vaccine on some genotypes
likely transmitted by ticks. For this analysis, we used the
msp4 genetic marker, which has been used before for the
characterization of genetic diversity in these species [17].
The results showed a high genetic diversity for A. mar-
ginale in cattle (11 msp4 genotypes; Figure 10A-C), a
finding common to cattle herds in Sicily [38] and other
regions of the world [39,40]. Genotype frequencies were
different between vaccinated and control farms and be-
tween samples collected before and after vaccination
(Figure 10A and B). Interestingly, the analysis of the
most frequent genotypes showed an effect of cattle vac-
cination with SUB-MSP1a on decreasing the frequency
for genotype AmA, but not for AmE and AmH geno-
types (Figure 10D). These results suggested an effect ofhe A. ovis msp4 coding region was amplified by PCR, sequenced and
) control sheep. Dashed line represents time of last immunization shot.
me using Excel and represented only when the correlation coefficient
compared to the reference sequence (GenBank accession number
don ATG corresponds to position 1) with polymorphisms were
sequence.
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http://www.parasitesandvectors.com/content/7/1/10the vaccine in reducing the frequency for A. marginale
genotype AmA, probably reflecting the reduction in the
percent of tick-infested animals shown in cattle vacci-
nated with SUB-MSP1a that reduces the prevalence of a
tick-transmitted strain. As in previous studies [39,41],
the genetic diversity for A. ovis (4 msp4 genotypes) was
lower when compared to A. marginale (Figure 11A-C).
Differences were not observed in A. ovis msp4 genotype
frequency between vaccinated and control sheep nor be-
fore and after vaccination with SUB-MSP1a (Figure 11A
and B).Conclusions
To our knowledge, this is the first vaccine trial assessing
the control of multiple tick species infestations and
pathogen prevalence in cattle and sheep and the first
field trial using the SUB-MSP1a vaccine. The main find-
ings of these studies were that (a) both cattle and sheep
developed antibodies in response to vaccination; (b) the
main effect of the vaccine in cattle was the reduction in
the percent of infested animals but not in the tick infest-
ation rate in these animals; (c) vaccination in sheep did
not affect the percent of infested animals but reduced
tick infestations; (d) female tick weight was lower in
ticks collected from both vaccinated cattle and sheep
when compared to controls; (e) lower B. bigemina sero-
prevalence in vaccinated cattle suggested a role for the
vaccine in decreasing the prevalence of this tick-borne
pathogen; and (f ) the effect of the vaccine in reducing
the frequency of one A. marginale genotype probably
reflected the reduction in the prevalence of a tick-
transmitted strain as a result of the reduction in the per-
cent of tick-infested cattle. The lower female tick
weights are likely to impact and decrease tick popula-
tions over time because it has been well documented
that lower female tick engorgement weights correlate
with the oviposition of smaller egg masses. This trend
would likely reduce tick populations over time. As has
been noted previously, tick vaccines are likely to be an
important component of integrated tick control methods
and would likely reduce the use of acaricides.
These results provide new evidence to support that
SUB-based vaccines have the dual effect of controlling
tick infestations and pathogen infection/transmission,
thus reducing tick populations and their vector cap-
acity to impact on the control of tick-borne diseases
[42]. These results also provide additional support for
the use of the vaccine containing E. coli membranes
with the surface-exposed SUB-MSP1a chimera as a
low-cost and effective alternative for tick control in
cattle and sheep, even under conditions with multiple
tick species infestations and the prevalence of several
tick-borne pathogens.Additional file
Additional file 1: Additional information on host antibody
response, tick infestations and pathogen prevalence.
Supplementary figures.
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